Amundi Asset Management US’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $78.4M | Sell |
165,712
-37,328
| -18% | -$17.7M | 0.06% | 320 |
|
|
2020
Q4 | $98.1M | Sell |
203,040
-17,695
| -8% | -$8.55M | 0.08% | 261 |
|
|
2020
Q3 | $124M | Buy |
220,735
+7,077
| +3% | +$3.96M | 0.13% | 162 |
|
|
2020
Q2 | $133M | Buy |
213,658
+86,736
| +68% | +$54.1M | 0.16% | 129 |
|
|
2020
Q1 | $62M | Sell |
126,922
-49,540
| -28% | -$24.2M | 0.11% | 185 |
|
|
2019
Q4 | $66.3M | Buy |
176,462
+51,304
| +41% | +$19.3M | 0.08% | 256 |
|
|
2019
Q3 | $34.7M | Buy |
125,158
+31,000
| +33% | +$8.6M | 0.05% | 365 |
|
|
2019
Q2 | $29.5M | Sell |
94,158
-134,803
| -59% | -$42.2M | 0.02% | 472 |
|
|
2019
Q1 | $94M | Sell |
228,961
-1,726
| -0.7% | -$709K | 0.13% | 161 |
|
|
2018
Q4 | $86.2K | Buy |
230,687
+74,827
| +48% | +$27.9K | 0.08% | 174 |
|
|
2018
Q3 | $63M | Buy |
155,860
+106,563
| +216% | +$43.1M | 0.08% | 240 |
|
|
2018
Q2 | $17M | Sell |
49,297
-35,768
| -42% | -$12.3M | 0.02% | 565 |
|
|
2018
Q1 | $29.3M | Buy |
85,065
+14,837
| +21% | +$5.11M | 0.05% | 383 |
|
|
2017
Q4 | $26.4M | Buy |
+70,228
| New | +$26.4M | 0.04% | 396 |
|
|
2016
Q1 | – | Sell |
-391
| Closed | -$212K | – | 572 |
|
|
2015
Q4 | $212K | Buy |
+391
| New | +$212K | ﹤0.01% | 536 |
|
|
2015
Q2 | – | Sell |
-482
| Closed | -$218K | – | 642 |
|
|
2015
Q1 | $218K | Buy |
+482
| New | +$218K | ﹤0.01% | 594 |
|